Myriad Genetics (MYGN) Financials: Revenue & Earnings
MYGN$6.51+0.22 +3.54%
$622.92M
Market Cap
-5.26
P/E
—
Forward P/E
34
Score
Myriad Genetics (MYGN) Financials: Revenue & Earnings
MYGN price $6.51 +0.22 +3.54%
- Ticker
- MYGN
- Price
- $6.51
- Change
- +0.22 +3.54%
- Market cap ?
- $622.92M
- P/E ?
- -5.26
- Dividend yield ?
- 0.00%
- Beta ?
- 1.64
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Stocklytics score
- 34
- Value
- 58
- Quality
- 37
- Growth
- 8
Stocklytics score rationale: value 58, quality 37, growth 8.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 728700000 | 743700000 | 851100000 | 638600000 | 557000000 | 690600000 | 678400000 | 753200000 | 837600000 | 824500000 |
Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women’s health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic test, a DNA sequencing test for metastatic breast, ovarian, metastatic…
Fair value
MYGN fair value $6.00. Price $6.51. Price is 8% above fair value.
Above fair value, but less expensive than usual. A smaller premium than on 66% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 113.26M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 1.6). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 95.65M. Net debt 60.20M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-04 | — | -0.17 | — | 191.33M |
| 2026-07-30 | -0.25 | -0.06 | 190.70M | 206.03M |
| 2026-05-05 | -0.09 | -0.06 | 200.40M | 202.42M |
| 2026-02-23 | 0.04 | -0.02 | 209.80M | 207.44M |
| 2025-11-03 | -0.13 | -0.01 | 205.70M | 206.96M |
| 2025-08-05 | 0.05 | -0.01 | 213.10M | 205.24M |
| 2025-05-06 | -0.03 | -0.05 | 195.90M | 211.71M |
| 2025-02-24 | 0.03 | 0.03 | 210.60M | 210.35M |
| 2024-11-07 | 0.06 | 0.02 | 213.30M | 213.56M |
| 2024-08-06 | 0.05 | 0.01 | 211.50M | 204.95M |
| 2024-05-07 | -0.01 | -0.11 | 202.20M | 193.51M |
| 2024-02-27 | 0.04 | 0.01 | 196.60M | 194.78M |
| 2023-11-06 | -0.03 | -0.08 | 191.90M | 194.03M |
| 2023-08-03 | -0.08 | -0.10 | 183.50M | 187.13M |
| 2023-05-03 | -0.21 | -0.19 | 181.20M | 171.55M |
| 2023-02-28 | -0.12 | -0.16 | 177.80M | 169.47M |
| 2022-11-01 | -0.19 | -0.06 | 156.40M | 170.07M |
| 2022-08-04 | 0.04 | 0.01 | 179.30M | 170.96M |
| 2022-05-05 | -0.03 | -0.05 | 164.90M | 156.67M |
| 2022-02-24 | -0.02 | -0.02 | 160.80M | 162.96M |
| 2021-11-02 | -0.02 | 0.01 | 167.30M | 166.30M |
| 2021-08-03 | 0.12 | -0.07 | 189.40M | 165.11M |
| 2021-05-03 | -0.06 | -0.14 | 173.10M | 156.20M |
| 2021-02-23 | -0.12 | -0.12 | 154.60M | 150.39M |
| 2020-11-09 | -0.15 | -0.33 | 145.20M | 196.02M |
| 2020-08-13 | -0.31 | -0.36 | 93.20M | 141.30M |
| 2020-05-05 | -0.08 | -0.01 | 164.00M | 20.50M |
| 2020-02-06 | 0.23 | 0.31 | 195.10M | 246.00M |
| 2019-11-04 | 0.08 | 0.33 | 186.30M | 745.20M |
| 2019-08-13 | 0.41 | 0.47 | 215.40M | 246.92M |
| 2019-05-07 | 0.46 | 0.44 | 216.60M | 197.77M |
| 2019-02-05 | 0.38 | 0.41 | 216.80M | 222.51M |
| 2018-11-06 | 0.43 | 0.30 | 202.30M | 141.14M |
| 2018-08-21 | 0.38 | 0.33 | 200.90M | 169.26M |
| 2018-05-08 | 0.31 | 0.27 | 193.50M | 168.53M |
| 2018-02-06 | 0.31 | 0.24 | 194.00M | 150.19M |
| 2017-11-07 | 0.26 | 0.21 | 190.20M | 153.62M |
| 2017-08-08 | 0.30 | 0.26 | 200.50M | 173.77M |
| 2017-05-02 | 0.27 | 0.24 | 196.90M | 167.73M |
| 2017-02-07 | 0.26 | 0.24 | 196.50M | 181.38M |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency Monthly.
Safety score 43/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividend history is short. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| 2009-07-01 | $1.75 | — | — | Monthly |
| 2009-06-15 | $1.75 | — | — | Monthly |
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-21 | Wheeler Benjamin Richard | Sell | 2.56K | $4.01 | 10.25K |
| 2026-09-16 | Donnelly Brian J | Other | 0 | — | — |
| 2026-09-16 | Sikri Vishal | Buy | 257.73K | — | — |
| 2026-09-16 | Sikri Vishal | Other | 0 | — | — |
| 2026-09-03 | Fox Jennifer Lynne | Sell | 4.40K | $3.23 | 14.21K |
| 2026-08-16 | Wheeler Benjamin Richard | Sell | 8.76K | $3.03 | 26.55K |
| 2026-06-23 | Skovronsky Daniel | Other | 0 | — | — |
| 2026-06-11 | Raha Samraat S. | Buy | 3.54K | $3.94 | 13.94K |
| 2026-06-11 | Donnelly Brian J | Buy | 5.00K | $3.94 | 19.68K |
| 2026-06-08 | Kumar Rashmi | Sell | 15.00K | $4.46 | 66.84K |
| 2026-06-04 | Skovronsky Daniel | Buy | 59.70K | — | — |
| 2026-06-04 | Newcomer Lee Nisley | Buy | 59.70K | — | — |
| 2026-06-04 | Davis Mark Steven | Buy | 59.70K | — | — |
| 2026-06-04 | Phanstiel S. Louise | Buy | 59.70K | — | — |
| 2026-06-04 | Dreismann Heinrich | Buy | 59.70K | — | — |
| 2026-06-04 | Reitan Colleen F | Buy | 59.70K | — | — |
| 2026-06-04 | Bisaro Paul | Buy | 59.70K | — | — |
| 2026-06-04 | Kumar Rashmi | Buy | 59.70K | — | — |
| 2026-06-01 | Jampa Raj | Buy | 251.89K | — | — |
| 2026-06-01 | Jampa Raj | Other | 0 | — | — |
| 2026-05-14 | Bisaro Paul | Buy | 7.50K | $3.69 | 27.64K |
| 2026-05-01 | Donnelly Brian J | Sell | 55.98K | $4.80 | 268.68K |
| 2026-04-14 | Verratti Mark | Sell | 1.07K | $4.91 | 5.25K |
| 2026-04-14 | Muzzey Dale | Sell | 946 | $4.91 | 4.64K |
| 2026-03-22 | Muzzey Dale | Sell | 2.02K | $4.58 | 9.25K |
| 2026-03-22 | Verratti Mark | Sell | 2.06K | $4.58 | 9.41K |
| 2026-03-22 | Wheeler Benjamin Richard | Sell | 549 | $4.58 | 2.51K |
| 2026-03-15 | Haas Kevin Richard | Sell | 3.35K | $4.66 | 15.63K |
| 2026-03-15 | Haas Kevin Richard | Sell | 8.38K | $4.66 | 39.06K |
| 2026-03-15 | Muzzey Dale | Sell | 4.78K | $4.66 | 22.29K |
| 2026-03-15 | Muzzey Dale | Sell | 11.95K | $4.66 | 55.68K |
| 2026-03-15 | Verratti Mark | Sell | 5.61K | $4.66 | 26.15K |
| 2026-03-15 | Verratti Mark | Sell | 9.10K | $4.66 | 42.39K |
| 2026-03-15 | Wheeler Benjamin Richard | Sell | 877 | $4.66 | 4.09K |
| 2026-03-15 | Wheeler Benjamin Richard | Sell | 2.19K | $4.66 | 10.21K |
| 2026-03-14 | Haas Kevin Richard | Sell | 4.16K | $4.66 | 19.39K |
| 2026-03-14 | Solaiman Shereen | Sell | 5.78K | $4.66 | 26.95K |
| 2026-03-14 | Muzzey Dale | Sell | 8.29K | $4.66 | 38.62K |
| 2026-03-14 | Verratti Mark | Sell | 5.42K | $4.66 | 25.25K |
| 2026-03-14 | Wheeler Benjamin Richard | Sell | 1.10K | $4.66 | 5.11K |
| 2026-03-14 | Raha Samraat S. | Sell | 10.82K | $4.66 | 50.40K |
| 2026-03-13 | Haas Kevin Richard | Sell | 6.41K | $4.66 | 29.88K |
| 2026-03-13 | Solaiman Shereen | Sell | 8.90K | $4.66 | 41.47K |
| 2026-03-13 | Muzzey Dale | Sell | 12.78K | $4.66 | 59.55K |
| 2026-03-13 | Fox Jennifer Lynne | Sell | 6.00K | $4.66 | 27.94K |
| 2026-03-13 | Verratti Mark | Sell | 9.16K | $4.66 | 42.70K |
| 2026-03-13 | Wheeler Benjamin Richard | Sell | 586 | $4.66 | 2.73K |
| 2026-03-13 | Raha Samraat S. | Sell | 36.30K | $4.66 | 169.18K |
| 2026-03-12 | Solaiman Shereen | Buy | 173.20K | — | — |
| 2026-03-12 | Muzzey Dale | Buy | 173.20K | — | — |
| 2026-03-12 | Fox Jennifer Lynne | Buy | 195.88K | — | — |
| 2026-03-12 | Donnelly Brian J | Buy | 226.80K | — | — |
| 2026-03-12 | Verratti Mark | Buy | 247.42K | — | — |
| 2026-03-12 | Wheeler Benjamin Richard | Buy | 206.19K | — | — |
| 2026-03-12 | Raha Samraat S. | Buy | 618.56K | — | — |
| 2026-03-09 | Raha Samraat S. | Buy | 40.00K | $5.00 | 199.84K |
| 2026-03-01 | Solaiman Shereen | Sell | 1.68K | $4.61 | 7.72K |
| 2026-02-27 | Phanstiel S. Louise | Buy | 48.00K | $4.66 | 223.73K |
| 2026-02-26 | Phanstiel S. Louise | Buy | 50.41K | $4.80 | 242.10K |
| 2026-02-25 | Phanstiel S. Louise | Buy | 6.10K | $4.74 | 28.89K |
| 2026-02-02 | Wheeler Benjamin Richard | Buy | 4.99K | — | — |
| 2026-02-02 | Verratti Mark | Buy | 32.81K | — | — |
| 2026-02-02 | Muzzey Dale | Buy | 23.70K | — | — |
| 2026-02-02 | Haas Kevin Richard | Buy | 23.70K | — | — |
| 2026-01-01 | Muzzey Dale | Sell | 418 | $6.15 | 2.57K |
| 2025-12-25 | Wheeler Benjamin Richard | Sell | 21 | $6.55 | 138 |
| 2025-12-11 | Raha Samraat S. | Sell | 29.63K | $7.30 | 216.33K |
| 2025-11-03 | Ancona Margaret | Other | 0 | — | — |
| 2025-10-24 | Munk Natalie | Other | 0 | — | — |
| 2025-09-21 | Verratti Mark | Sell | 1.08K | $7.77 | 8.43K |
| 2025-09-21 | Munk Natalie | Sell | 962 | $7.77 | 7.47K |
| 2025-09-21 | Wheeler Benjamin Richard | Sell | 2.56K | $7.77 | 19.88K |
| 2025-09-21 | Ancona Margaret | Sell | 958 | $7.77 | 7.44K |
| 2025-09-03 | Fox Jennifer Lynne | Sell | 4.43K | $6.80 | 30.16K |
| 2025-08-18 | Leffler Scott J. | Other | 0 | — | — |
| 2025-08-16 | Wheeler Benjamin Richard | Buy | 60.00K | — | — |
| 2025-08-16 | Wheeler Benjamin Richard | Other | 0 | — | — |
| 2025-06-05 | Dreismann Heinrich | Buy | 49.80K | — | — |
| 2025-06-05 | Bisaro Paul | Buy | 49.80K | — | — |
| 2025-06-05 | Davis Mark Steven | Buy | 24.15K | — | — |
| 2025-06-05 | Phanstiel S. Louise | Buy | 49.80K | — | — |
| 2025-06-05 | Newcomer Lee Nisley | Buy | 49.80K | — | — |
| 2025-06-05 | Reitan Colleen F | Buy | 49.80K | — | — |
| 2025-06-05 | Kumar Rashmi | Buy | 49.80K | — | — |
| 2025-06-05 | Skovronsky Daniel | Buy | 49.80K | — | — |
| 2025-05-31 | Raha Samraat S. | Buy | 1.50K | $3.56 | 5.34K |
| 2025-05-01 | Donnelly Brian J | Buy | 127.63K | — | — |
| 2025-05-01 | Donnelly Brian J | Buy | 269.90K | — | — |
| 2025-05-01 | Donnelly Brian J | Buy | 236.17K | — | — |
| 2025-05-01 | Donnelly Brian J | Other | 0 | — | — |
| 2025-04-30 | Verratti Mark | Buy | 105.78K | — | — |
| 2025-04-30 | Raha Samraat S. | Buy | 141.05K | — | — |
| 2025-04-30 | DIAZ PAUL J | Other | 0 | — | — |
| 2025-04-14 | Muzzey Dale | Sell | 942 | $8.08 | 7.61K |
| 2025-04-14 | Verratti Mark | Sell | 1.08K | $8.08 | 8.77K |
| 2025-03-25 | Munk Natalie | Sell | 362 | $9.73 | 3.52K |
| 2025-03-24 | Munk Natalie | Sell | 393 | $9.98 | 3.92K |
| 2025-03-24 | Munk Natalie | Sell | 589 | $9.98 | 5.88K |
| 2025-03-24 | Haas Kevin Richard | Sell | 1.18K | $9.98 | 11.75K |
| 2025-03-24 | Haas Kevin Richard | Sell | 1.72K | $9.98 | 17.21K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 201, holders -4 vs prior quarter. Ownership 95.78%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 10.89M | 2.00M | +22.51% | 62.18M |
| MILLENNIUM MANAGEMENT LLC | 6.62M | -48.45K | -0.73% | 37.80M |
| VESTAL POINT CAPITAL, LP | 5.74M | 4.09M | +248.00% | 32.75M |
| STATE STREET CORP | 4.99M | 561.03K | +12.68% | 28.46M |
| D. E. SHAW & CO., INC. | 4.58M | 82.36K | +1.83% | 26.16M |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.08M | 156.85K | +4.00% | 23.30M |
| ACADIAN ASSET MANAGEMENT LLC | 3.13M | 818.38K | +35.45% | 17.84M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.08M | 497.44K | +19.26% | 17.58M |
| AQR CAPITAL MANAGEMENT LLC | 2.77M | 854.39K | +44.68% | 15.80M |
| MORGAN STANLEY | 2.48M | -687.64K | -21.70% | 14.17M |
| GEODE CAPITAL MANAGEMENT, LLC | 2.42M | 96.82K | +4.17% | 13.80M |
| GOLDMAN SACHS GROUP INC | 2.06M | -309.25K | -13.07% | 11.74M |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.89M | -196.97K | -9.43% | 10.80M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 1.74M | 1.74M | New | 9.94M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.74M | -60.68K | -3.37% | 9.94M |
| QUBE RESEARCH & TECHNOLOGIES LTD | 1.67M | -24.63K | -1.46% | 9.51M |
| FEDERATED HERMES, INC. | 1.57M | -405.85K | -20.54% | 8.97M |
| TWO SIGMA INVESTMENTS, LP | 1.56M | 273.68K | +21.31% | 8.89M |
| NUVEEN, LLC | 1.55M | 626.59K | +68.18% | 8.83M |
| MACKENZIE FINANCIAL CORP | 1.54M | 1.54M | New | 8.77M |
| CITADEL ADVISORS LLC | 1.53M | 1.08M | +238.53% | 8.76M |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 1.41M | 89.20K | +6.76% | 8.04M |
| ABERDEEN GROUP PLC | 1.31M | 198.53K | +17.88% | 7.47M |
| MARSHALL WACE, LLP | 1.22M | 119.05K | +10.79% | 6.98M |
| DIMENSIONAL FUND ADVISORS LP | 1.05M | 312.94K | +42.34% | 6.01M |
Earnings and financials
Myriad Genetics, Inc. (MYGN) trades at $6.51, with a market cap of $622.92M and a trailing P/E of -5.26. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 728700000 | 743700000 | 851100000 | 638600000 | 557000000 | 690600000 | 678400000 | 753200000 | 837600000 | 824500000 |
Insights · Dividends · Forecast · Financials · Learn